Trial intelligence / Profile preview

Indomethacin for Systemic Inflammation in Acute Pancreatitis

2014-004844-37Phase 3Active

Sponsor
Enrique de Madaria Pascual
Start
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of indomethacin in acute pancreatitis (AP) (2 arms), sponsored by Enrique de Madaria Pascual. Primary endpoint: Change in mean SIRS score at 48 hours. Started May 2015; status: active.

02

Drugs

indomethacin
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on 2014-004844-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004844-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call